Kurin
Kurin is a privately owned, minority-certified business dedicated to improving healthcare through innovative, cost-effective, clinician-approved technologies. The company focuses on reducing false positive blood cultures and has developed products like the Kurin Lock® family and Kurin Jet™ to enhance blood culture collection practices, improve diagnostic accuracy, and promote patient safety.
Industries
Nr. of Employees
small (1-50)
Kurin
Products
Blood culture collection sets with initial-specimen diversion
Single-use blood collection sets that passively sideline the initial small-volume blood specimen prior to collection to reduce skin-derived contamination during venipuncture and peripheral IV draws.
Rapid integrated diversion device for venipuncture and PIV
A diversion-enabled blood draw accessory intended to be used without additional workflow steps to lower contamination rates and meet institutional benchmarks.
Blood culture collection sets with initial-specimen diversion
Single-use blood collection sets that passively sideline the initial small-volume blood specimen prior to collection to reduce skin-derived contamination during venipuncture and peripheral IV draws.
Rapid integrated diversion device for venipuncture and PIV
A diversion-enabled blood draw accessory intended to be used without additional workflow steps to lower contamination rates and meet institutional benchmarks.
Services
Clinical education and resource portal
Online portal and downloadable materials to train clinical staff on blood culture collection best practices and device use; supports compliance and implementation.
Clinical evidence and implementation support
Support for prospective audits, study participation, and post-implementation outcome measurement to evaluate contamination rates and clinical impact.
Clinical education and resource portal
Online portal and downloadable materials to train clinical staff on blood culture collection best practices and device use; supports compliance and implementation.
Clinical evidence and implementation support
Support for prospective audits, study participation, and post-implementation outcome measurement to evaluate contamination rates and clinical impact.
Expertise Areas
- Blood culture contamination reduction
- Medical device engineering and disposable device development
- Clinical study design, execution and publication
- FDA 510(k) regulatory pathway and device registration
Key Technologies
- Initial specimen diversion for blood cultures
- Blood culture collection set design for venipuncture and PIV
- Integrated diversion devices compatible with standard workflow
- Clinical audit and prospective/retrospective study methods